GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Impedimed Ltd (OTCPK:IPDQF) » Definitions » Construction In Progress

IPDQF (Impedimed) Construction In Progress : $0.00 Mil (As of Dec. 2024)


View and export this data going back to . Start your Free Trial

What is Impedimed Construction In Progress?


Impedimed Construction In Progress Historical Data

The historical data trend for Impedimed's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Impedimed Construction In Progress Chart

Impedimed Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Impedimed Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Impedimed Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.


Impedimed Business Description

Traded in Other Exchanges
Address
50 Parker Court, Unit 1, Pinkenba, QLD, AUS, 4008
Impedimed Ltd, together with its subsidiaries, operates in the medical devices space. The company is based in Australia and operates globally, and it generates the majority of its revenue in North America. It is engaged in developing, manufacturing, and distributing noninvasive medical devices. The company offers products that are typically used to assess and monitor lymphedema and heart failure, as well as to measure the tissue composition and fluid status of the patients. The company also offers a cloud-based digital platform (branded as SOZO) to manage patient data. The company recognizes revenue from the stand-alone sale of Legacy Devices and Consumables, the Sale of SOZO Devices, and Software Subscription Services.

Impedimed Headlines

From GuruFocus

Q3 2021 ImpediMed Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2023 ImpediMed Ltd Cashflow Reports Call Transcript

By GuruFocus Research 02-14-2024

Full Year 2022 ImpediMed Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2023 ImpediMed Ltd Activities Report Call Transcript

By GuruFocus Research 02-14-2024

Q2 2022 ImpediMed Ltd Activities Report Call Transcript

By GuruFocus Research 02-14-2024

Q3 2022 ImpediMed Ltd Activities Report Call Transcript

By GuruFocus Research 02-14-2024

Q4 2020 ImpediMed Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

ImpediMed Ltd Corporate Call Transcript

By GuruFocus Research 02-14-2024

Full Year 2024 ImpediMed Ltd Earnings Call Transcript

By GuruFocus Research 09-14-2024